The Bench of Primary Breast Lymphoma Treatment: A Review of the Literature and a Case Report
Résumé
Background: Primary non-Hodgkin breast lymphoma is a rare pathology, representing 0.5 percent of malignant breast tumors.
Case Presentation: Here, we report a 54-year-old female presenting a mass in the left breast diagnosed by needle biopsy and IHC as a diffuse large B-cell lymphoma (DLBCL). Radiation therapy with conventional fields was applied for whole breast irradiation after the patient received 6 courses of R-CHOP (Rituximab plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone) chemotherapy. At the follow-up period 11 months after radiation therapy, no morbidities occurred and the patient is surviving with no evidence of disease.
Conclusions: The common treatments for breast lymphomas are surgery, radiation therapy, and chemotherapy. Although no agreement has been reached on the best therapy for primary breast lymphomas, these methods are commonly applied alone or in combination. It seems that R-CHOP combined with radiation therapy regimen could be an important treatment modality in avoiding unnecessary surgery.
Case Presentation: Here, we report a 54-year-old female presenting a mass in the left breast diagnosed by needle biopsy and IHC as a diffuse large B-cell lymphoma (DLBCL). Radiation therapy with conventional fields was applied for whole breast irradiation after the patient received 6 courses of R-CHOP (Rituximab plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone) chemotherapy. At the follow-up period 11 months after radiation therapy, no morbidities occurred and the patient is surviving with no evidence of disease.
Conclusions: The common treatments for breast lymphomas are surgery, radiation therapy, and chemotherapy. Although no agreement has been reached on the best therapy for primary breast lymphomas, these methods are commonly applied alone or in combination. It seems that R-CHOP combined with radiation therapy regimen could be an important treatment modality in avoiding unnecessary surgery.
##article.full_articles##
##article.generated_from_xml##
Auteurs-es
1.
Karimkhani Zandi S, Heidari F. The Bench of Primary Breast Lymphoma Treatment: A Review of the Literature and a Case Report. Arch Breast Cancer [Internet]. 10 déc. 2017 [cité 14 oct. 2025];4(4):141-5. Disponible à: https://www.archbreastcancer.com/index.php/abc/article/view/148
Télécharger la référence
Endnote/Zotero/Mendeley (RIS)
(c) Tous droits réservés Archives of Breast Cancer 2017
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale 4.0 International.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.